JPH0662408B2 - Anti-caries and anti-periodontal composition - Google Patents
Anti-caries and anti-periodontal compositionInfo
- Publication number
- JPH0662408B2 JPH0662408B2 JP62248303A JP24830387A JPH0662408B2 JP H0662408 B2 JPH0662408 B2 JP H0662408B2 JP 62248303 A JP62248303 A JP 62248303A JP 24830387 A JP24830387 A JP 24830387A JP H0662408 B2 JPH0662408 B2 JP H0662408B2
- Authority
- JP
- Japan
- Prior art keywords
- caries
- periodontal disease
- present
- oral
- streptococcus mutans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、う蝕及び歯周病の予防に有効な組成物に関す
る。TECHNICAL FIELD The present invention relates to a composition effective in preventing dental caries and periodontal disease.
本発明の、抗う蝕及び抗歯周病組成物は優れた抗う蝕作
用及び抗歯周病作用を有しており、砂糖含有飲料物、特
に菓子やアメ等を食べる機会が多い幼児のう蝕や成人の
う蝕により誘発される歯周病の予防に極めて有効であ
る。The anti-caries and anti-periodontal disease composition of the present invention has excellent anti-caries and anti-periodontal disease effects, and caries of infants who often eat sugar-containing beverages, especially sweets and candy. It is extremely effective in preventing periodontal disease induced by caries in adults and adults.
(従来の技術) 口腔外科領域の2大疾患である、う蝕及び歯周病の原因
は、いずれも口腔内細菌が引き金となって発生すること
が近年の研究により明かにされている。(Prior Art) Recent studies have revealed that the causes of dental caries and periodontal disease, which are two major diseases in the field of oral surgery, are triggered by oral bacteria.
特に、口腔内細菌ストレプトコッカス・ミュータンス
(Streptococcus mutans)が飲食
物中のショ糖から粘着性のある多糖を合成し、その合成
された多糖中でストレプトコッカス・ミュータンスをは
じめ種々の細菌(乳酸菌やグラム陰性菌)が繁殖し遂に
菌叢とも云うべき歯垢を形成する。また、ストレプトコ
ッカス・ミュータンス等の細菌は、種々の糖から乳酸な
どの有機酸を生成し、この有機酸が歯垢中に滞留してエ
ナメル層を侵し、う蝕を誘発する。更には歯垢中のグラ
ム陰性菌毒素による歯周病の発生を引き起こすことが知
られている。In particular, the oral bacterium Streptococcus mutans synthesizes a sticky polysaccharide from sucrose in food and drink, and various bacteria such as Streptococcus mutans such as lactic acid bacteria and gram are synthesized in the synthesized polysaccharide. Negative bacteria) propagate and finally form plaque, which should be called the flora. Bacteria such as Streptococcus mutans produce organic acids such as lactic acid from various sugars, and the organic acids stay in dental plaque to attack the enamel layer and induce dental caries. Furthermore, it is known that gram-negative bacterial toxin in dental plaque causes periodontal disease.
従って、このう蝕や歯周病の発生を予防するためには、
歯垢を形成する原因菌であるストレプトコッカス・ミュ
ータンスの増殖を抑制することが最も効果的な方法であ
る。Therefore, in order to prevent the occurrence of this dental caries and periodontal disease,
The most effective method is to suppress the growth of Streptococcus mutans, which is the causative agent of plaque formation.
従来、ストレプトコッカス・ミュータンスの口腔内への
定着を抑制するためクロールヘキシジンのような殺菌剤
或るいは、各種の抗生物質が検討されてきた(浜田茂幸
「虫歯はどうしてできるか」1982年2月22日,岩
波新書P125〜P133)。Heretofore, in order to suppress the colonization of Streptococcus mutans in the oral cavity, a fungicide such as chlorhexidine or various kinds of antibiotics have been studied (Shigeyuki Hamada, “How Can I Make Caries?”, 1982 2 22 May, Iwanami Shinsho P125-P133).
しかしながらこれらの技術では、必ずしも満足すべき結
果が得られていない。すなわちクロールヘキシジンなど
の殺菌剤は毒性が高く不快な苦味があり、かつ歯や口腔
粘膜が着色するという欠点をも有する。また一般に、抗
生物質や殺菌剤は長期連用に不適であり、口腔内細菌を
無差別に死滅させて、常在菌叢の均衡をくずすづために
菌交代症などを引き起こす。また、ときには腸内細菌に
まで影響する等、好ましからぬ状況をもたらすことが多
い。However, these techniques do not always give satisfactory results. That is, bactericides such as chlorhexidine are highly toxic and have an unpleasant bitterness, and also have the drawback of coloring teeth and oral mucosa. In general, antibiotics and bactericides are unsuitable for long-term continuous use, indiscriminately killing oral bacteria and disrupting the balance of the indigenous flora, resulting in bacterial metaplasia. In addition, it often causes unfavorable situations, such as affecting even intestinal bacteria.
(発明が解決しようとする問題点) 本発明者らは、ストレプトコッカス・ミュータンスに対
して特異的に抗菌作用を示し、かつ長期の連用に於て安
全性の高い物質を探すべく鋭意研究を重ねた結果、ツバ
キ科の植物,特に我々が日常飲料に供している茶に含ま
れるポリフェノール化合物が優れた抗う蝕及び抗菌周病
活性を有することを見い出した。(Problems to be Solved by the Invention) The inventors of the present invention have conducted extensive studies to find a substance that exhibits a specific antibacterial action against Streptococcus mutans and is highly safe for long-term continuous use. As a result, it was found that the plants of the Camellia family, especially the polyphenol compounds contained in the tea we use for daily drinks have excellent anti-caries and anti-bacterial disease activities.
(問題点を解決するめの手段) 本発明者らは、茶(Camellia sinensi
s,(L.)O.Kuntze)に含まれるポリフェノ
ール化合物を有効成分とする安全性の高い優れた、抗う
蝕及び抗菌周病組成物を得ることを成功した。(Means for Solving Problems) The present inventors have found that tea (Camellia sinensi)
s, (L.) O. It has succeeded in obtaining a highly safe and excellent anti-caries and anti-bacterial perioperative composition containing a polyphenol compound contained in Kuntze) as an active ingredient.
本発明のポリフェノール化合物とは、特許請求の範囲記
載の(1)式及び(2)式で表される第1表に示した5
種類のカテキン類緑体化合物をさす。The polyphenol compound of the present invention means 5 shown in Table 1 represented by the formulas (1) and (2) in the claims.
Refers to a class of catechin chloroplast compounds.
本発明のポリフェノール化合物は、茶の水もしくはアル
コール抽出物の酢酸エチル可溶画分より得ることができ
るが、他の原料起源のもの及び化学合成品でもさしつか
えない。 The polyphenol compound of the present invention can be obtained from an ethyl acetate-soluble fraction of tea water or an alcohol extract, but may be derived from other raw materials or a chemically synthesized product.
本発明のポリフェノール化合物の典型的調製法を例示す
ると次のようである。The typical method for preparing the polyphenol compound of the present invention is as follows.
まず茶を十分量の水もしくは、アルコールで室温抽出す
る。抽出後、公知の方法にて残渣を分離し抽出液を得
る。抽出液から溶媒を留去し、その残留物に水を加え溶
解後ヘキサン,クロロホルム及び酢酸エチルを順次用い
て分配を行い、ヘキサン可溶画分,クロロホルム可溶画
分及び酢酸エチル可溶画分を得る。本操作におけるヘキ
サン及びクロロホルムによる分配は、水もしくはアルコ
ール抽出物の着色度及び粘度等の状況により省略するこ
とができるが、酢酸エチル可溶画分の純度を上げるため
には、ヘキサン及びクロロホルムによる分配の実施が望
ましい。First, tea is extracted at room temperature with a sufficient amount of water or alcohol. After extraction, the residue is separated by a known method to obtain an extract. The solvent was distilled off from the extract, water was added to the residue to dissolve it, and the mixture was partitioned using hexane, chloroform and ethyl acetate in that order, and the hexane soluble fraction, chloroform soluble fraction and ethyl acetate soluble fraction were separated. To get The distribution with hexane and chloroform in this operation can be omitted depending on the coloring and viscosity of the water or alcohol extract, but in order to increase the purity of the ethyl acetate-soluble fraction, the distribution with hexane and chloroform can be omitted. Is desirable.
抽出に用いうるアルコールは、メチルアルコール,エチ
ルアルコール,n−プロピルアルコール,イソプロピル
アルコール,ブチルアルコール等の低級アルコールが操
作性・抽出効率の点から好ましい。As the alcohol that can be used for extraction, lower alcohols such as methyl alcohol, ethyl alcohol, n-propyl alcohol, isopropyl alcohol and butyl alcohol are preferable from the viewpoint of operability and extraction efficiency.
更に上記で得られた酢酸エチル可溶画分をシリカゲルカ
ラムクロマトグラフィーに付し、クロロホルム−メタノ
ール(20:1,V/V)及びクロロホルム−メタノー
ル(10:1,V/V)の溶媒にて順次溶出することに
より第1表の6種化合物を得ることができる。また必要
に応じて更にセファデックスLH−20に付し、適当な
溶媒例えばメタノールにて溶出することにより、或るい
は、リサイクルHPLC(日本分析工業製,LC−90
8,GS−320カラム,溶媒メタノール)を用いるこ
とにより、より高純度の第1表の6種化合物を得ること
ができる。Furthermore, the ethyl acetate-soluble fraction obtained above was subjected to silica gel column chromatography using chloroform-methanol (20: 1, V / V) and chloroform-methanol (10: 1, V / V) solvents. By sequentially eluting, the 6 kinds of compounds shown in Table 1 can be obtained. If necessary, it is further applied to Sephadex LH-20 and eluted with a suitable solvent such as methanol, or recycled HPLC (manufactured by Nippon Analytical Industry Co., LC-90
8, GS-320 column, solvent methanol), it is possible to obtain higher purity 6 compounds of Table 1.
このポリフェノール化合物は、茶の抗う蝕性成分として
報告がある無機フッ素類(池ケ谷賢次郎,食品と開発,
vol122,No.3.P22)とは明らかに異な
り、その効果について本発明によりはじめて明らかにさ
れたものである。This polyphenol compound is an inorganic fluorine which has been reported as an anti-cariogenic component of tea (Kenjiro Ikegaya, Food and Development,
vol122, No. 3. It is clearly different from P22), and its effect was first clarified by the present invention.
(作用) 本発明の抗う蝕及び抗歯周病組成物の有効成分であるポ
リフェノール化合物は、口腔内細菌ストレプトコッカス
・ミュータンスに対する抗菌性試験において極めて優れ
た結果を示した。う蝕及び歯周病の予防に有用なこれら
の作用につき、以下に試験例を挙げて詳細に説明する。(Effect) The polyphenol compound, which is the active ingredient of the anti-caries and anti-periodontal disease composition of the present invention, showed extremely excellent results in the antibacterial test against the oral bacterium Streptococcus mutans. These effects, which are useful for the prevention of dental caries and periodontal disease, will be described in detail below with reference to test examples.
試験例 抗菌活性の測定 試験管に5mlのブレインハートインヒュージョン(B
HI)培地を加え、120℃,15分間オートクレーブ
した後、これにメチルアルコールに溶解された試料溶液
100μlと、予め24〜48時間培養された菌の懸濁
液100μlを加え、37℃にて静置培養する。BHI
培地中の試料濃度は表中に示す。培養24時間及び48
時間後の生菌数を1.5%寒天添加BHI培地上にて測
定した。対照には試料溶液の代わりにメタノールのみを
加えた。Test example Measurement of antibacterial activity 5 ml of Brain Heart Infusion (B
HI) medium was added and autoclaved at 120 ° C. for 15 minutes, and then 100 μl of a sample solution dissolved in methyl alcohol and 100 μl of a suspension of bacteria previously cultured for 24 to 48 hours were added, and the mixture was statically incubated at 37 ° C. Incubate. BHI
The sample concentration in the medium is shown in the table. Culture 24 hours and 48
The viable cell count after the lapse of time was measured on a BHI medium supplemented with 1.5% agar. For the control, only methanol was added instead of the sample solution.
試料 1.第1表の化合物I 2.第1表の化合物II 3.第1表の化合物III 4.第1表の化合物IV 5.第1表の化合物V 試験に用いた菌体 1.ストレプトコッカス・ミュータンス(Strept
ococcus mutans MT8148) 第2表〜第7表は、ストレプトコッカス・ミュータンス
に対するポリフェノール化合物の抗菌試験の結果であ
る。化合物I,II,III,IV及びVのいずれもストレプ
トコッカス・ミュータンスに対し増殖阻止効果を示し
た。増殖阻止濃度は化合物I,III及びVは、いずれも
500μg/mlであり、化合物IIIは、より低濃度の
125μg/mlであった。試験に用いたストレプトコ
ッカス・ミュータンスMT8148株は、日本人児童の
虫歯感染者に多くみられる血清型C型の菌であることか
らも、本発明の抗う蝕及び抗歯周病組成物の有効性が証
明される。しかも、本発明のポリフェノール化合物は、
古くから飲用に供されている茶由来のものであり、茶の
成分として多量に含まれていることから、その安定性は
歴史的経験から既に実証されている。また口腔に何ら刺
激を与えず、歯牙の着色などの害作用も示さないことか
らも、う蝕及び歯周病予防効果を有する成分として使用
するのに極めて好適な物質である。Sample 1. Compound I of Table 1 2. Compound II in Table 1 3. Compound III of Table 1 4. Compound IV of Table 1 5. Compound V in Table 1 Cells used in the test 1. Streptococcus mutans
ococcus mutans MT8148) Tables 2 to 7 show the results of antibacterial tests of polyphenol compounds against Streptococcus mutans. Compounds I, II, III, IV and V all showed a growth inhibitory effect on Streptococcus mutans. The growth inhibitory concentrations of Compounds I, III and V were all 500 μg / ml, and Compound III was a lower concentration of 125 μg / ml. Since the Streptococcus mutans MT8148 strain used in the test is a serotype C bacterium that is often found in caries-infected Japanese children, the efficacy of the anticaries and anti-periodontal disease composition of the present invention is also effective. Is proven. Moreover, the polyphenol compound of the present invention is
It is derived from tea that has been used for drinking since ancient times, and its stability has already been verified from historical experience because it is contained in large amounts as a tea ingredient. Further, since it does not cause any irritation to the oral cavity and shows no harmful effects such as coloring of teeth, it is a very suitable substance to be used as a component having a caries and periodontal disease preventing effect.
使用態様 本発明のポリフェノール化合物を、う蝕予防用或るいは
歯周病予防用組成物として使用するためには適当な口腔
用製剤として使用するのが好ましい。この様の口腔用製
剤は、液剤,固形剤,半固形剤のいずれであってもよ
く、好ましい製剤としては、歯みがき剤,含嗽剤,トロ
ーチ剤,うがい薬,塗布液剤,チューインガム等があげ
られる。Mode of Use The polyphenol compound of the present invention is preferably used as a suitable oral preparation for use as a composition for caries prevention or periodontal disease prevention. Such an oral preparation may be a liquid preparation, a solid preparation, or a semisolid preparation, and preferable preparations include a dentifrice, a mouthwash, a troche, a mouthwash, a coating liquid, chewing gum and the like.
これらの口腔用製剤を製造するのに使用される賦形剤,
または補助剤は、通常この種の目的に使用されるものか
ら剤形に応じて適宜選択すればよく、特に制限されるも
のではないが、例えば乳糖,デンプン,コーンスター
チ,ステアリン酸マグネシウム,第2燐酸カルシウム・
2水和物,ソルビット,カルボキシメチルセルロース,
サッカリン,ラウリル硫酸ナトリウム,グリセリン,ソ
ジウムカルボキシメチルセルロース,無水ケイ酸,ゼラ
チン,二酸化チタン,メントール,脂肪酸,クエン酸,
ポリエチレングリコール,ソジウムラウロイルサルコシ
ネート,炭酸カルシウム,アルコール,カラギーナン,
ソジウムアシルタウレート,ペプトン,アラビアゴム,
ラウリルジエタノールアミド等が使用される。Excipients used to make these oral formulations,
Or, the auxiliary agent may be appropriately selected from those usually used for this type of purpose according to the dosage form, and is not particularly limited, and examples thereof include lactose, starch, corn starch, magnesium stearate, and diphosphoric acid. calcium·
Dihydrate, sorbit, carboxymethyl cellulose,
Saccharin, sodium lauryl sulfate, glycerin, sodium carboxymethyl cellulose, silicic acid anhydride, gelatin, titanium dioxide, menthol, fatty acid, citric acid,
Polyethylene glycol, sodium lauroyl sarcosinate, calcium carbonate, alcohol, carrageenan,
Sodium acyl taurate, peptone, gum arabic,
Lauryl diethanolamide or the like is used.
上記の製剤に、フッ化ナトリウム,フッ化リン,フッ化
リン酸ナトリウムなどのフッ化物を配合し、そのう蝕予
防効果を一層高めることもでき、塩化ナトリウムを加え
たり保存剤,香料及び着色剤等を適宜添加することもで
きる。Fluoride such as sodium fluoride, phosphorus fluoride and sodium fluorophosphate can be added to the above-mentioned preparation to further enhance the caries prevention effect, and sodium chloride can be added or a preservative, a fragrance and a coloring agent. Etc. can also be added as appropriate.
この様にして製造されるう蝕予防用或るいは歯周病予防
用の口腔製剤中に占める本発明のポリフェノール化合物
の量は剤形によっても異なるが、通常重量で約0.00
1%(重量/重量)以上であることが望ましい。The amount of the polyphenol compound of the present invention in the oral preparation for preventing dental caries or for preventing periodontal disease thus produced varies depending on the dosage form, but is usually about 0.000 by weight.
It is preferably 1% (weight / weight) or more.
(実施例) 次に、本発明を実施例により、詳しく説明するが、これ
により本発明を限定するものではない。(Examples) Next, the present invention will be described in detail with reference to Examples, but the present invention is not limited thereto.
[実施例−1] 歯磨剤 [実施例−2] 含嗽剤 [実施例−3] トローチ剤 [実施例−4] チューインガム (発明の効果) 本発明のポリフェノール化合物は、う蝕及び歯周病誘発
の原因となる歯垢を生成する主要な原因菌であるストレ
プトコッカス・ミュータンスに対し、強い抗菌活性を示
す。[Example-1] Dentifrice [Example-2] Gargle [Example-3] Lozenge agent [Example-4] Chewing gum (Effect of the Invention) The polyphenol compound of the present invention exhibits a strong antibacterial activity against Streptococcus mutans, which is a main causative bacterium that produces dental plaque that causes dental caries and periodontal disease.
本発明に用いられる原料のポリフェノール化合物は、古
来より飲用に供されている茶の成分であることからその
安全制は極めて高く、その強い抗う蝕及び抗歯周病組成
物を大量に供給することが可能であり、口腔衛生の改善
に貢献することは勿論産業的にも極めて有用であると考
えられる。Since the raw material polyphenol compound used in the present invention is a component of tea that has been used for drinking since ancient times, its safety system is extremely high, and a large amount of its strong anti-caries and anti-periodontal disease composition should be supplied. It is considered that it is possible to contribute to the improvement of oral hygiene and of course it is extremely useful industrially.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭59−144779(JP,A) ─────────────────────────────────────────────────── ─── Continuation of the front page (56) References JP-A-59-144779 (JP, A)
Claims (1)
2は水素原子または、3,4,5−トリハイドロキシベ
ンゾイル基 を示す) で表されるポリフェノール化合物を有効成分とする抗う
蝕及び抗歯周病組成物。Claims (1) and (2) below (In the formula, R 1 represents a hydrogen atom or a hydroxyl group, and R 1
2 is a hydrogen atom or a 3,4,5-trihydroxybenzoyl group An anti-caries and anti-periodontal disease composition comprising a polyphenol compound represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62248303A JPH0662408B2 (en) | 1987-10-01 | 1987-10-01 | Anti-caries and anti-periodontal composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62248303A JPH0662408B2 (en) | 1987-10-01 | 1987-10-01 | Anti-caries and anti-periodontal composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21304596A Division JP2903210B2 (en) | 1996-07-23 | 1996-07-23 | Periodontal disease induction inhibitor composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6490124A JPS6490124A (en) | 1989-04-06 |
JPH0662408B2 true JPH0662408B2 (en) | 1994-08-17 |
Family
ID=17176068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62248303A Expired - Fee Related JPH0662408B2 (en) | 1987-10-01 | 1987-10-01 | Anti-caries and anti-periodontal composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0662408B2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2979514B2 (en) * | 1988-07-14 | 1999-11-15 | 株式会社伊藤園 | Method for producing caries preventive agent |
JPH02295923A (en) * | 1989-05-10 | 1990-12-06 | Taiyo Kagaku Co Ltd | Reproduction-inhibiting composition for enteral destructive fungus |
FR2652743B1 (en) * | 1989-10-11 | 1994-05-27 | Cariel Leon | COMPOSITION BASED ON PROANTHOCYANIDOLS. THEIR PHARMACOLOGICAL APPLICATION. |
JPH0314572A (en) * | 1989-06-12 | 1991-01-23 | Norin Suisansyo Yasai Chiyagiyou Shikenjo | Production of catechins of plant body |
US4935256A (en) * | 1989-10-31 | 1990-06-19 | Procter & Gamble Company | Process for making green tea solids |
JPH03218320A (en) * | 1989-11-10 | 1991-09-25 | Itouen:Kk | Preventive for periodontosis and foul breath |
JPH0725670B2 (en) * | 1990-07-18 | 1995-03-22 | 株式会社ロッテ | Anti periodontal drug |
JPH05944A (en) * | 1991-06-21 | 1993-01-08 | Taiyo Kagaku Co Ltd | Composition for inhibiting adhesion of periodontosis causative microorganism |
GB2300578B (en) * | 1995-05-11 | 1998-01-14 | Matsushita Seiko Kk | Gargling cup,antiviral mask,antiviral filter,antifungal,antibacterial,and antiviral filter air cleaner and air-cleaner-humidifier |
US5888527A (en) * | 1995-05-11 | 1999-03-30 | Matsushita Seiko Co., Ltd. | Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-cleaner humidifier |
FR2792530B1 (en) * | 1999-04-21 | 2001-06-22 | Berkem Sa | PREPARATION OF A MEDICAMENT CONTAINING CATECHIC OR FLAVONILIC-TYPE POLYPHENOLIC COMPOUNDS OF PLANT ORIGIN, PARTICULARLY FOR THE TREATMENT OF GINGIVITIS |
WO2002092028A2 (en) | 2001-05-15 | 2002-11-21 | The Procter & Gamble Company | Oral care compositions |
US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
CA2484192C (en) | 2002-04-30 | 2012-10-02 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
US8945518B2 (en) | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
BRPI0409179A (en) | 2003-04-04 | 2006-05-02 | Unigen Pharmaceuticals Inc | formulation of dual cyclooxygenase (cox) and lipoxygenase (lox) inhibitors for mammalian skin care |
US7846422B2 (en) | 2003-08-04 | 2010-12-07 | Kao Corporation | Method for prevention or treatment of periodontal diseases and composition for an oral cavity |
TW200630102A (en) * | 2004-10-19 | 2006-09-01 | Unigen Pharmaceuticals Inc | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
JP5963383B2 (en) * | 2005-06-06 | 2016-08-03 | 株式会社明治 | Oral care composition |
EP1928268A1 (en) * | 2005-09-30 | 2008-06-11 | DSMIP Assets B.V. | Novel compositions containing polyphenols |
EP2045248B1 (en) | 2006-07-21 | 2013-09-25 | Kao Corporation | Method for preventing coloration of catechins and dentifrice composition |
CN102875691B (en) * | 2012-10-19 | 2015-02-25 | 黄冈师范学院 | Method for synchronously preparing active substances from tea dregs |
JP7164757B1 (en) * | 2021-12-21 | 2022-11-01 | 大木製▲薬▼株式会社 | Oral microflora improving agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4285964A (en) * | 1979-08-30 | 1981-08-25 | Continental Pharma | Salts of (+)-catechine, their preparation and use, and compositions containing these salts |
DE3123211A1 (en) * | 1981-06-11 | 1983-01-05 | Unilever N.V., 3000 Rotterdam | ORAL CARE PRODUCTS |
JP2519024B2 (en) * | 1982-06-07 | 1996-07-31 | 花王株式会社 | Hair cosmetics |
JPS59219384A (en) * | 1983-05-30 | 1984-12-10 | Mitsui Norin Kk | Preparation of natural antioxidant |
-
1987
- 1987-10-01 JP JP62248303A patent/JPH0662408B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPS6490124A (en) | 1989-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0662408B2 (en) | Anti-caries and anti-periodontal composition | |
JP4948044B2 (en) | Plaque formation inhibitor or anti-cariogenic agent | |
JP3241955B2 (en) | Oral composition | |
EP0348560A1 (en) | Oral composition | |
JP2903210B2 (en) | Periodontal disease induction inhibitor composition | |
KR940006065B1 (en) | Dentifrice compositions for using carious tooth tooth root disease | |
JP2848688B2 (en) | Oral composition | |
JPH03240721A (en) | Composition for oral cavity | |
KR19980013946A (en) | Oral composition of liquid type | |
JPH0225413A (en) | Preventive for dental caries | |
JPH0769886A (en) | Anticariogenic antiperiodontic agent and oral cavity composition containing the agent | |
JP6432594B2 (en) | Oral biofilm calcification inhibitor and oral composition | |
KR100492034B1 (en) | Antibacterial agent and oral composition for preventing and treating caries and periodontal disease containing panduratin derivatives | |
JP3009531B2 (en) | Periodontal disease prevention agent | |
JPH0427204B2 (en) | ||
EP0376162B1 (en) | Dental plaque inhibitor | |
KR20020082308A (en) | Composition for the mouth containing extraction of Euonymus alatus Sieb | |
JPH07133222A (en) | Glucosyl transferase inhibitor | |
JPH0627067B2 (en) | Oral composition | |
JP2001089344A (en) | Anti-dental caries agent | |
JPS641441B2 (en) | ||
JPS6258324B2 (en) | ||
JPH0434968B2 (en) | ||
JPH0225890B2 (en) | ||
KR20200114023A (en) | Oral composition containing Nux-Vomica extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |